JUN 22, 2017 10:30 AM PDT

WEBINAR: Laboratory and Clinical Benefits of Rapid Blood Culture Diagnostics

C.E. CREDITS: P.A.C.E. CE | Florida CE
  • Director of Clinical Microbiology Operations, Memorial Sloan Kettering Cancer Center
      Esther Babady, Ph.D., is the Director of Clinical Operations for the Microbiology Laboratory Service and an associate attending in the Department of Laboratory Medicine at Memorial Sloan-Kettering Cancer (MSKCC) in New York City. She also serves as the director of the CPEP clinical microbiology fellowship program at MSKCC. She received her PhD in Biochemistry and Molecular Biology and completed a post-doctoral CPEP fellowship in Clinical Microbiology both at the Mayo Clinic in Rochester, MN before joining MSKCC. She is board certified by the American Board of Medical Microbiology and serves on the editorial board of the Journal of Clinical Microbiology. Her research interests include rapid diagnosis of infections in immunocompromised hosts, the development and evaluation of the clinical utility of molecular microbiology assays.


    Unfortunately due to technical issues this webinar has been delayed until June 22nd. If you are unable to make the new time, it will be available on demand for you to view.

    DATE: June 22, 2017
    TIME: 10:30am PT, 1:30pm ET

    Sepsis is a major cause of morbidity and mortality in hospitalized patients. Diagnosis of sepsis is challenging and early recognition is a key component in improving outcomes. Blood culture remains the gold standard for diagnosis of sepsis but identification of bacterial or fungal pathogens using conventional methods is often delayed resulting in institution of empiric antimicrobial therapy. Clinical microbiology laboratories now have a few options for rapid identification of pathogens from positive blood cultures. These methods differ in their complexity, turn-around time to results, number of pathogens identified and costs.  This webinar will review current options for rapid pathogen identification from positive blood cultures and discuss the presenter’s experience with the use of AdvanDx QuickFISH BC kits and their impact on the laboratory workflow and patient outcomes.  

    Learning Objectives:

    • Discuss sepsis and the laboratory methods available for rapid diagnosis. 
    • Describe the benefits of rapid blood cultures diagnostics on laboratory workflow and clinical outcomes.

    Show Resources